Boguszewski, Cesar Luiz <br/><br/>
A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas.  [electronic resource] 

 -  Pituitary  Mar 2012 
 - 44-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-7403 
<br/><br/><label>Standard No.: </label>10.1007/s11102-011-0339-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Bromocriptine--administration & dosage<br/>Cabergoline<br/>Dopamine Agonists--adverse effects<br/>Echocardiography<br/>Ergolines--adverse effects<br/>Female<br/>Heart Valve Diseases--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Prolactinoma--drug therapy